Post by Luxembourg Institute of Health

This month's Voices of #Clinnova brings us to Luxembourg and highlights the perspective of Dr. Spyridon Sofos, Principal Investigator for the Clinnova IBD study at the Luxembourg Institute of Health. In this new episode, he reflects on the importance of long-term patient relationships and how Clinnova creates opportunities to learn from patients' experiences to continuously improve care for people living with inflammatory bowel disease. 💬 "As a clinician, I accompany many of my patients for years. Clinnova gives me a unique opportunity to learn from their experiences and continuously improve how I care for people living with inflammatory bowel disease." Thank you to Dr. Sofos Spyridon and the LIH team for sharing their voice and helping advance patient-centred digital medicine across Europe. 🔗 Don’t miss out, explore more about Clinnova at https://lnkd.in/e84xN_vP #VoicesOfClinnova #Clinnova #IBD #DigitalHealth #PersonalisedMedicine #PatientCentredCare Partners: Centre Hospitalier de Luxembourg, Hôpitaux Robert Schuman, Luxembourg Institute of Health, University of Luxembourg, LCSB, BioValley France, CHRU de Nancy, CHU de Reims, CHRU de Strasbourg - Hôpitaux Universitaires de Strasbourg, IHU INFINY - Institut des maladies inflammatoires chroniques de l'intestin, Institute of Image-Guided Surgery (IHU Strasbourg), INESIA by PRIeSM, Région Grand Est, PRIeSM, INSERM, IPHC - Institut Pluridisciplinaire Hubert Curien - CNRS, University of Strasbourg, Universite de Lorraine, Université de Reims Champagne-Ardenne, Bosch Digital Innovation Hub (BDIH) | Koordinierungsstelle Telemedizin Baden-Württemberg (KTBW), KTBW, Universitätsklinikum Freiburg Akademie für medizinische Berufe Freiburg im Breisgau, Universitätsmedizin Mannheim, MIRACUM Konsortium, University Hospital Basel, University of Basel, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clarunis – Universitäres Bauchzentrum Basel, Indivi ▶️ https://lnkd.in/e2wEcKk4